BDBM708509 3-(5-((5-(((3as, 6as)-hexahydro- 2,5-methanopentalen- 3a(1H)-yl)amino)pentyl) amino)-2-methyl-4- oxoquinazolin-3(4H)-yl) piperidine-2,6-dione::US20240425475, Compound GT-02496

SMILES Cc1nc2cccc(NCCCCCNC34CC5CC(CC3C5)C4)c2c(=O)n1C1CCC(=O)NC1=O

InChI Key InChIKey=YINQWPBUTXLGOD-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 708509   

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM708509(3-(5-((5-(((3as, 6as)-hexahydro- 2,5-methanopental...)
Affinity DataIC50: 420nMAssay Description:1. According to the instructions of the CEREBLON BINDING kits, the compounds to be tested of the present invention and lenalidomide were serially dil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent